Northwestern University's Richard Silverman and his work leading to the discovery and marketing of Pfizer's blockbuster, Lyrica, are profiled in this Chicago Tribune article. According to Silverman, who took one-fourth of the $700 million in royalties Northwestern made selling a portion of its rights to New York-based Royalty Pharma, finding a billion-dollar drug takes as much scientific curiosity as luck.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.